Investing.com - Can Fite Biopharma ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Can Fite Biopharma ADR announced earnings per share of $-0.25 on revenue of $250K. Analysts polled by Investing.com anticipated EPS of $-0.28 on revenue of $500K.
Can Fite Biopharma ADR shares are down 30.3% from the beginning of the year and are trading at $2.300 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Can Fite Biopharma ADR follows other major sector earnings this month
Can Fite Biopharma ADR's report follows an earnings beat by Tencent ADR on Wednesday, August 12, 2020, who reported EPS of $0.49 on revenue of $16.54B, compared to forecasts EPS of $0.41 on revenue of $16.07B.
L’Oreal ADR had beat expectations on Thursday, July 30, 2020 with second quarter EPS of $3.82 on revenue of $6.92B, compared to forecast for EPS of $0.85 on revenue of $6.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar